Delivery Order SPE2DR25D2014-SPE2DR26FA1Q7
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $136,229.40 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with a completion date of January 8, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This award represents a child contract under Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,289.12 by the Defense Logistics Agency's Medical Supply Chain on January 5, 2026. This competitively awarded, firm fixed-price contract (No. 4570392823) carries an ultimate completion date of January 6, 2026 and represents a child order under a larger contract vehicle. The award includes no set-aside designation, reflecting the contractor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,380.43 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of August 5, 2025. The award reflects AmerisourceBergen's established role as a critical...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $157,555.12 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a subsidiary of parent company Cencora, Inc. This competitively awarded, firm fixed-price contract is not set-aside and will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,768.94 on November 5, 2025, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for ultimate completion on November 6, 2025. This award was competitively awarded with no set-aside designation and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,024.80 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,287.20 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract represents a child award under Amerisourcebergen's parent company Cencora, Inc. and carries no set-aside designation. The delivery order falls under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $62,236.53 by the Defense Logistics Agency (DLA) on January 7, 2026, with an ultimate completion date of the same day. This non-set-aside competitive award is a child contract derived from Amerisourcebergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $943,263.97 by the Defense Logistics Agency's Medical Supply Chain on January 3, 2026. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of January 5, 2026 and represents a non-competitive set-aside contract. The award supports the federal...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $6,156.96 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA1Q7Delivery Order
On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,090.44 to AmerisourceBergen Drug Corp for E-Z Disk 700 mg tablets (100-count units), with an ultimate completion date of January 29, 2026. The contract employs firm fixed-price pricing and was awarded on a non-set-aside, competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a child contract under Cencora, Inc. (AmerisourceBergen's parent company), a major pharmaceutical distributor serving multiple federal agencies. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, a $999,999,999 pharmaceutical prime vendor vehicle running through December 2026 that enables global supply of medications and medical commodities to military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical products across therapeutic domains to support Defense Health Agency operations and other federal medical institutions, positioning it as a critical vendor within the federal medical supply chain serving military treatment facilities and government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/6/26 |